(Q35750204)

10 August 2017

1 reference

title

Nitric oxide and other novel therapies for pulmonary hypertension (English)

1 reference

10 August 2017

2

Joseph Loscalzo

1 reference

10 August 2017

1

Claudio Napoli

1 reference

10 August 2017

1 March 2004

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

10 August 2017

1 reference

10 August 2017

9

1 reference

10 August 2017

1

1 reference

10 August 2017

1-8

1 reference

Pulmonary hypertension: newer concepts in diagnosis and management.

10 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Genetic clues to the cause of primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

The structural basis of pulmonary hypertension in chronic lung disease: remodelling, rarefaction or angiogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Anorectic drugs and pulmonary hypertension from the bedside to the bench

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Signal transduction by the TGF-beta superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Nitric oxide insufficiency, platelet activation, and arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Medical management of primary pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

The biology of nitrogen oxides in the airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Regulation of endothelial nitric oxide synthase: location, location, location

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Inhaled nitric oxide for oligohydramnios-induced pulmonary hypoplasia: a report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: responders versus nonresponders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Evidence for in vivo transport of bioactive nitric oxide in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Plasma nitrosothiols contribute to the systemic vasodilator effects of intravenously applied NO: experimental and clinical Study on the fate of NO in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Administration of nitric oxide into open lung regions: delivery and monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Long-Term Treatment With Oral Sildenafil Is Safe and Improves Functional Capacity and Hemodynamics in Patients With Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Differential vasoactive response to endothelin receptor antagonists and prostacyclin in patients with severe pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Nitric oxide as a signaling molecule in the vascular system: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840400900I101

10.1177/107424840400900I101

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15094962